Sabba Stephen L, a director at Ligand Pharmaceuticals ($LGND), sold shares once on the open market in the last year, totaling about $410,000. His most recent sale occurred on March 3, 2026. This places him 6,892nd out of 11,678 insiders by sale value, below the average of $8.6 million across 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | S | Common Stock | 1000 | $207.87 | 32,793.0000 | 20,629,000 | 2.96% | 0.00% |
| March 3, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | M | Common Stock | 2034 | $69.51 | 35,827.0000 | 20,629,000 | 6.02% | 0.01% |
| March 3, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | M | Non- Qualified Stock Option (right to buy) | 2034 | $0.00 | 0.0000 | 20,629,000 | 100.00% | 0.01% |
| March 3, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | S | Common Stock | 2034 | $201.50 | 33,793.0000 | 20,629,000 | 5.68% | 0.01% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | A | Common Stock | 1209 | $0.00 | 33,793.0000 | 18,290,000 | 3.71% | 0.01% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | A | Non-Qualified Stock Option (right to buy) | 5783 | $0.00 | 5,783.0000 | 18,290,000 | 9999.99% | 0.03% |
| April 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | M | Non-Qualified Stock Option (right to buy) | 2406 | $0.00 | 0.0000 | 18,290,000 | 100.00% | 0.01% |
| April 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | M | Common Stock | 2406 | $52.30 | 32,584.0000 | 18,290,000 | 7.97% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | A | Non-Qualified Stock Option (right to buy) | 5444 | $0.00 | 5,444.0000 | 17,757,000 | 9999.99% | 0.03% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | A | Common Stock | 1252 | $0.00 | 30,178.0000 | 17,757,000 | 4.33% | 0.01% |
| March 5, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | S | Common Stock | 1893 | $74.30 | 28,926.0000 | 17,757,000 | 6.14% | 0.01% |
| March 5, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | M | Non-Qualified Stock Option (right to buy) | 2893 | $0.00 | 419.0000 | 17,757,000 | 87.35% | 0.02% |
| March 5, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Sabba Stephen L | Director | M | Common Stock | 2893 | $0.00 | 30,819.0000 | 17,757,000 | 10.36% | 0.02% |